STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer

被引:74
作者
Awasthi, Nagendra [1 ,2 ]
Liongue, Clifford [1 ,2 ]
Ward, Alister C. [1 ,2 ]
机构
[1] Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia
[2] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat IMPACT, Geelong, Vic, Australia
关键词
STAT; JAK; Cytokine; Transcription factor; Immunity; Cancer; SIGNAL TRANSDUCER; DNA-BINDING; TYROSINE PHOSPHORYLATION; UNPHOSPHORYLATED STAT3; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SERINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; JAK/STAT PATHWAY; CYCLOOXYGENASE-2; EXPRESSION;
D O I
10.1186/s13045-021-01214-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
STAT proteins represent an important family of evolutionarily conserved transcription factors that play key roles in diverse biological processes, notably including blood and immune cell development and function. Classically, STAT proteins have been viewed as inducible activators of transcription that mediate cellular responses to extracellular signals, particularly cytokines. In this 'canonical' paradigm, latent STAT proteins become tyrosine phosphorylated following receptor activation, typically via downstream JAK proteins, facilitating their dimerization and translocation into the nucleus where they bind to specific sequences in the regulatory region of target genes to activate transcription. However, growing evidence has challenged this paradigm and identified alternate 'non-canonical' functions, such as transcriptional repression and roles outside the nucleus, with both phosphorylated and unphosphorylated STATs involved. This review provides a revised framework for understanding the diverse kaleidoscope of STAT protein functional modalities. It further discusses the implications of this framework for our understanding of STAT proteins in normal blood and immune cell biology and diseases such as cancer, and also provides an evolutionary context to place the origins of these alternative functional modalities.
引用
收藏
页数:17
相关论文
共 162 条
[1]   Signal-induced repression: The exception or the rule in developmental signaling? [J].
Affolter, Markus ;
Pyrowolakis, George ;
Weiss, Alexander ;
Basler, Konrad .
DEVELOPMENTAL CELL, 2008, 15 (01) :11-22
[2]   Functional roles of STAT family proteins: Lessons from knockout mice [J].
Akira, S .
STEM CELLS, 1999, 17 (03) :138-146
[3]   Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose [J].
Amiri, F ;
Shaw, S ;
Wang, XD ;
Tang, J ;
Waller, JL ;
Eaton, DC ;
Marrero, MB .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1605-1616
[4]   A STAT-regulated, stress-induced signalling pathway in Dictyostelium [J].
Araki, T ;
Tsujioka, M ;
Abe, T ;
Fukuzawa, M ;
Meima, M ;
Schaap, P ;
Morio, T ;
Urushihara, H ;
Katoh, M ;
Maeda, M ;
Tanaka, Y ;
Takeuchi, I ;
Williams, JG .
JOURNAL OF CELL SCIENCE, 2003, 116 (14) :2907-2915
[5]   JAK/STAT signalling in Drosophila:: insights into conserved regulatory and cellular functions [J].
Arbouzova, Natalia I. ;
Zeidler, Martin P. .
DEVELOPMENT, 2006, 133 (14) :2605-2616
[6]  
Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931
[7]   STAT3 localizes to the ER, acting as a gatekeeper for ER- mitochondrion Ca2+ fluxes and apoptotic responses [J].
Avalle, Lidia ;
Camporeale, Annalisa ;
Morciano, Giampaolo ;
Caroccia, Natascia ;
Ghetti, Elena ;
Orecchia, Valeria ;
Viavattene, Daniele ;
Giorgi, Carlotta ;
Pinton, Paolo ;
Poli, Valeria .
CELL DEATH AND DIFFERENTIATION, 2019, 26 (05) :932-942
[8]   The molecular regulation of Janus kinase (JAK) activation [J].
Babon, Jeffrey J. ;
Lucet, Isabelle S. ;
Murphy, James M. ;
Nicola, Nicos A. ;
Varghese, Leila N. .
BIOCHEMICAL JOURNAL, 2014, 462 :1-13
[9]   INTERLEUKIN-12 INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT4 IN HUMAN-LYMPHOCYTES [J].
BACON, CM ;
PETRICOIN, EF ;
ORTALDO, JR ;
REES, RC ;
LARNER, AC ;
JOHNSTON, JA ;
O'SHEA, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7307-7311
[10]   JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects [J].
Banerjee, Shubhasree ;
Biehl, Ann ;
Gadina, Massimo ;
Hasni, Sarfaraz ;
Schwartz, Daniella M. .
DRUGS, 2017, 77 (05) :521-546